COMPANY
Amgen, Inc.
Amgen, Inc.: US labeler, trial sponsor, recalling firm for Etelcalcetide, Glucagon, Vasopressin, Carfilzomib, as stated by public registers.
Also written as: Amgen, Inc; Amgen Inc..
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Etelcalcetide | PARSABIV, NDA Regulator openFDA |
|---|
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Etelcalcetide | 1 registered trial Trial register EU CTIS |
|---|---|
| Glucagon | 1 registered trial Trial register EU CTIS |
| Vasopressin | 2 registered trials Trial register EU CTIS |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Carfilzomib | Class II recall, Terminated, 2016-12-28 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.